Delivery Order SPE2DB24D9105-SPE2DB24FBYTN

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $47,362.64, is for the delivery of 4564742782 Jakafi 10 mg tablet 60s. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $11,773.87 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,197 units of the 15 mg Jakafi tablet. This delivery order is part of DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery vehicle (IDV) contract with DLA, contract number 4600082013 under the SPE2DB program, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,773.87, is for the delivery of 4564859930 - Jakafi 15 mg Tablet 60s to support the medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC)...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,681.32 contract is for the delivery of Jakafi 10 mg tablets, a prescription medication used to treat certain types of cancer. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $11,840.66, is for the supply of 60 tablets of the 10 mg formulation of the drug Jakafi. The order was issued under an existing indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $47,399.24 contract is for the delivery of Jakafi 5 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, valued at up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical products to military health facilities...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $47,399.24 contract is for the delivery of Jakafi 5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,549.43, is for the delivery of Jakafi 5 mg tablets. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for a wide range of pharmaceutical products to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,840.66, is a delivery order for the delivery of 60 tablets of the prescription drug Jakafi 10 mg. The contract has no set-aside designation. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $71,043.96, is for the delivery of Jakafi 10 mg tablets over the period ending on May 7, 2024. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery...
  • SPE2DB24D9105
    Indefinite Delivery Contract
  • SPE2DB24D9105-SPE2DB24FBYTN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,849.81 firm fixed-price delivery order is for the supply of Jakafi 5 mg tablets. It is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This IDC, which runs through December 31, 2025, does not have a set-aside designation. Through this contract vehicle and other prime vendor agreements, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 11/28/24, 9:26 AM